Ethics and research assessing the relative roles of genes and the environment

Accountability in Research

Volumn 11, Issue 3-4, 2004, Pages 161-182

  DeCamp, Matthew ^a   Sugarman, Jeremy ^b  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Environmental genetics; Ethics; Genetic research; Population genetics; Research standards; Research subjects

Indexed keywords

BIOMEDICAL AND BEHAVIORAL RESEARCH; ENVIRONMENTAL EXPOSURE; EPIDEMIOLOGY; ETHICS; ETHNIC GROUP; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETICS; GENETICS AND REPRODUCTION; HUMAN; METHODOLOGY; PHARMACOGENETICS; PUBLIC HEALTH; RACE; REVIEW; TOXICOGENETICS; WORKPLACE;

BIOMEDICAL AND BEHAVIORAL RESEARCH; GENETICS AND REPRODUCTION;

CONTINENTAL POPULATION GROUPS; ENVIRONMENTAL EXPOSURE; EPIDEMIOLOGIC STUDIES; ETHNIC GROUPS; GENETIC PREDISPOSITION TO DISEASE; GENETIC RESEARCH; GENETIC SCREENING; HUMANS; PHARMACOGENETICS; PUBLIC HEALTH; RESEARCH DESIGN; TOXICOGENETICS; WORKPLACE;

EID: 20344393621     PISSN: 08989621     EISSN: 15455815     Source Type: Journal    
DOI: 10.1080/08989620490891359     Document Type: Review

References (102)

1. Aardema, M. J., and J. T. MacGregor. 2002. Toxicology and genetic toxicology in the new era of "toxicogenomics": Impact of "-omics" technologies. Mutation Research 499(1):13-25.
2. Absher, R. K., M. E. Moore, and M.H. Parker. 2002. Patient-specific factors predictive of warfarin dosage requirements. The Annals of Pharmacotherapy 36(10): 1512-7.
3. Anthony, J. C., W. W. Eaton, and A. S. Henderson. 1995. Looking to the future in psychiatric epidemiology. Epidemiologic Reviews 17(1):240-2.
4. Austin, M. A., P. A. Peyser, and M. J. Khoury. 2000. The interface of genetics and public health: research and educational challenges. Annual Review of Public Health 21:81-99.
5. Berkowitz, G. S., M. S. Wolff, T. Matte, E. Susser, and P. J. Landrigan. 2001. The rationale for a national prospective cohort study of environmental exposure and childhood development. Environmental Research 85(2):59-68.
6. Bloche, M. G. 2004. Race-based therapeutics. New England Journal of Medicine. 351(20):2035.
7. Block, G. D. and M. I. Aulisio. 2000. Will genetics revolutionize medicine? New England Journal of Medicine 343(20):1496; discussion 1498.
8. Burke, W., S. S. Coughlin, N. C. Lee, D. L. Weed, and M. J. Khoury. 2001. Application of population screening principles to genetic screening for adult-onset conditions. Genetic Testing 5(3):201-11.
9. Canfield, R. L., C. R. Henderson Jr., D. A. Cory-Slechta, C. Cox, T. A. Jusko, and B. P. Lanphear. 2003. Intellectual impairment in children with blood lead concentrations below 10 microg per deciliter. New England Journal of Medicine 348(16):1517-26.
10. Centers for Disease Control 1991 Preventing lead poisoning in young children: A statement. Atlanta, GA: The Centers for Disease Control.
11. Childress, J. F., R. R. Faden, R. D. Gaare, L. O. Gostin, J. Kahn, R. J. Bonnie, N. E. Kass, A. C. Mastroianni, J. D. Moreno, and P. Nieburg. 2002. Public health ethics: mapping the terrain. Journal of Law, Medicine & Ethics 30(2):170-8.
12. Christiani, D. C., R. R. Sharp, G. W. Collman, and W. A. Suk. 2001. Applying genomic technologies in environmental health research: challenges and opportunities. Journal of Occupational and Environmental Medicine 43(6):526-33.
13. Clayton, E. W. 2000. Genetics, public health, and the law. In Genetics and Public Health in the 21st Century: Using Genetic Information to Improve Health and Prevent Disease, edited by M. J. Khoury, W. Burke, and E. Thomson. New York: Oxford University Press.
14. Colditz, G. A., W. C. Willett, D. J. Hunter, M. J. Stampfer, J. E. Manson, C. H. Hennekens, and B. A. Rosner. 1993. Family history, age, and risk of breast cancer. Prospective data from the Nurses' Health Study. Journal of the American Medical Association 270(3):338-43
15. Collins, F.S. 2004 The case for a U.S. prospective cohort study of genes and environment. Nature 429(6990):475-7.
16. Cooper, R. S. 2003. Gene-environment interactions and the etiology of common complex disease. Annals of Internal Medicine 139(5 Pt 2):437-40.
17. Cooper, R. S., J. S. Kaufman, and R. Ward. 2003. Race and genomics. New England Journal of Medicine 348(12):1166-70.
18. Coughlin, S. S. 1999. The intersection of genetics, public health, and preventive medicine. American Journal of Preventive Medicine 16(2):89-90.
19. DeCamp, M. and J. Sugarman. 2003. Ethics in population-based genetic research. Accountability in Research 11(1):1-26.
20. Eaton, W. 2002. The logic for a conception-to-death cohort study. Annals of Epidemiology 12(7):445-51.
21. Ference, B. A., M. S. Chauhan, and S. Izumo. 2000. Will genetics revolutionize medicine? New England Journal of Medicine 343(20):1497-8.
22. Foster, M. W. and R. R. Sharp. 2002. Race, ethnicity, and genomics: Social classifications as proxies of biological heterogeneity. Genome Research 12(6):844-50.
23. Gerard, S., M. Hayes, and M. A. Rothstein. 2002. On the edge of tomorrow: Fitting genomics into public health policy. Journal of Law, Medicine & Ethics 30(3 Suppl):173-6.
24. Giguere, Y. and F. Rousseau. 2000. The genetics of osteoporosis: 'Complexities and difficulties'. Clinical Genetics 57(3):161-9.
25. Glantz, L. H. 2002. Nontherapeutic research with children: Grimes v Kennedy Krieger Institute. American Journal of Public Health 92(7):1070-3.
26. Gorlova, O. Y., C. Amos, C. Henschke, L. Lei, M. Spitz, Q. Wei, X. Wu, and M. Kimmel. 2003. Genetic susceptibility for lung cancer: Interactions with gender and smoking history and impact on early detection policies. Human Heredity 56(1-3): 139-45.
27. Gottlieb, S. 2001. U.S. employer agrees to stop genetic testing. British Medical Journal 322(7284):449.
28. Haga, S. B., M. J. Khoury, and W. Burke. 2003. Genomic profiling to promote a healthy lifestyle: Not ready for prime time. Nature Genetics 34(4):347-50.
29. Han, J., S. E. Hankinson, H. Ranu, I. De Vivo, and D. J. Hunter. 2004. Polymorphisms in DNA double strand break repair genes and breast cancer risk in the Nurses' Health Study. Carcinogenesis 25(2):189-95.
30. Hill, A. V. 2001. The genomics and genetics of human infectious disease susceptibility. Annual Review of Genomics and Human Genetics 2:373-400.
31. Holden, C. 2003. Race and medicine. Science 302(5645):594-6.
32. Holtzman, N. 2001. Is public health ready for genetics? Archives of Pediatrics and Adolescent Medicine 155(2):117-8.
33. Holtzman, N. A. 2003. Expanding newborn screening: how good is the evidence? Journal of the American Medical Association 290(19):2606-8.
34. Holtzman, N. A. and T. M. Marteau. 2000. Will genetics revolutionize medicine? New England Journal of Medicine 343(2):141-4.
35. Institute of Medicine Committee for the Study of the Future of Public Health. 1988. The Future of Public Health. Washington, DC: National Academy Press.
36. Jansson, R., C. Watts, A. Katz, P. Kuzler, A. C. Mastroianni, J. Thompson, and A. McWilliam. 2000. Genetic testing in the workplace: Implications for public policy: Available at http://depts.washington.edu/phgen/PilotProjects/Genetic%20Testing%20in%20the%20Workplace.PDF. Accessed June 2004.
37. Johnson, A. 2003. The genetic key to public health. State Legislatures 29(2):28-30.
38. Kahn, J. 2003. Getting the numbers right: Statistical mischief and racial profiling in heart failure research. Perspectives in Biology and Medicine 46(4):473-83.
39. Kaplan, J. B. and T. Bennett. 2003. Use of race and ethnicity in biomedical publication. Journal of the American Medical Association 289(20):2709-2716.
40. Kass, N. E. 2001. An ethics framework for public health. American Journal of Public Health 91(11):1776-82.
41. Kaufman, J. S. and R. S. Cooper. 2001. Commentary: Considerations for use of racial/ ethnic classification in etiologic research. American Journal of Epidemiology 154(4): 291-298.
42. Kelada, S. N., D. L. Eaton, S. S. Wang, N. R. Rothman, and M. J. Khoury. 2003. The role of genetic polymorphisms in environmental health. Environmental Health Perspectives 111(8):1055-64.
43. Khoury, M. J. 1996. From genes to public health: The applications of genetic technology in disease prevention. Genetics Working Group. American Journal of Public Health 86(12):1717-22.
44. Khoury, M. J. 2000. Will genetics revolutionize medicine? New England Journal of Medicine 343(20):1497; discussion 1498.
45. Khoury, M. J., W. Burke, and E. Thomson. 2000. In Genetics and public health: A framework for the integration of human genetics into public health. Genetics and Public Health in the 21st Century: Using Genetic Information to Improve Health and Prevent Disease. M. J. Khoury, W. Burke and E. Thomson. New York: Oxford University Press.
46. Khoury, M. J., J. Little, and W. Burke, Eds. 2003. Human Genome Epidemiology: A Scientific Foundation for Using Genetic Information to Improve Health and Prevent Disease. New York: Oxford University Press.
47. Koh, D. and J. Jeyaratnam. 1998. Biomarkers, screening and ethics. Occupational Medicine (Oxford, England) 48(1):27-30.
48. Kopelman, L. M. 2002. Group benefit and protection of pediatric research subjects: Grimes v. Kennedy Krieger and the Lead Abatement Study. Accountability in Research 9(3-4):177-92.
49. Krumm, J. 2002. Genetic discrimination. Why congress must ban genetic testing in the workplace. The Journal of Legal Medicine 23(4):491-521.
50. Kulkarni, P. S., S. T. Butera, and A. C. Duerr. 2003. Resistance to HIV-1 infection: Lessons learned from studies of highly exposed persistently seronegative (HEPS) individuals. AIDS Reviews 5(2):87-103.
51. Langheier, J. M. and R. Snyderman. 2004. Prospective medicine: The role for genomics in personalized health planning. Pharmacogenomics 5(1):1-8.
52. Lanphear, B. P., K. N. Dietrich, and O. Berger. 2003. Prevention of lead toxicity in U.S. children. Ambulatory Pediatrics 3(1):27-36.
53. Lash, L. H., R. N. Hines, F. J. Gonzalez, T. R. Zacharewski, and M. A. Rothstein. 2003. Genetics and susceptibility to toxic chemicals: Do you (or should you) know your genetic profile? Journal of Pharmacology and Experimental Therapeutics 305(2): 403-9.
54. Lindpaintner, K. 2003. Pharmacogenetics and the future of medical practice. Journal of Molecular Medicine 81(3):141-53.
55. Little, J., M. J. Khoury, L. Bradley, M. Clyne, M. Gwinn, B. Lin, M. L. Lindegren, and P. Yoon. 2003. The Human Genome Project is complete. How do we develop a handle for the pump? American Journal of Epidemiology 157(8):667-73.
56. Long, J., C. Covington, V. Delaney-Black, and B. Nordstrom. 2002. Allelic variation and environmental lead exposure in urban children. AACN Clinical Issues 13(4): 550-6.
57. MacQueen, K. M., Q. A. Karim, and J. Sugarman. 2003. Ethics guidance for HIV prevention trials. British Medical Journal 327(7410):340.
58. Marchant, G. E. 2002. Toxicogenomics and toxic torts. Trends in Biotechnology 20(8):329-32.
59. Marshall, E. 2003. Preventing toxicity with a gene test. Science 302(5645):588-90.
60. Mastroianni, A. C. and J. P. Kahn. 2002. Risk and responsibility: Ethics, Grimes v Kennedy Krieger, and public health research involving children. American Journal of Public Health 92(7):1073-6.
61. McBride, C. M., G. Bepler, I. M. Lipkus, P. Lyna, G. Samsa, J. Albright, S. Datta, and B. K. Rimer. 2002. Incorporating genetic susceptibility feedback into a smoking cessation program for African-American smokers with low income. Cancer Epidemiology, Biomarkers & Prevention 11(6):521-8.
62. Melzer, D., A. Raven, D. E. Detmer, T. Ling, and R. L. Zimmern. 2003. My very own medicine: what must I know? Information policy for pharmacogenetics. Cambridge: University of Cambridge. Available at http://www.phgu.org.uk/about_phgu/pharmacogenetics.html. Accessed March 2004.
63. Merikangas, K. R. and N. Risch. 2003. Genomic priorities and public health. Science 302(5645):599-601.
64. Moldrup, C. 2001. Ethical, social and legal implications of pharmacogenomics: A critical review. Community Genetics 4(4):204-14.
65. Morris, J., M. Gwinn, M. Clyne, and M. J. Khoury. 2003. Public knowledge regarding the role of genetic susceptibility to environmentally induced health conditions. Community Genetics 6(1):22-8.
66. National Children's Study Interagency Coordinating Committee. 2003. The National Children's Study of environmental effects on child health and development. Environmental Health Perspectives 111(4):642-6.
67. Nelson, R. M. 2001. Nontherapeutic research, minimal risk, and the Kennedy Krieger lead abatement study. IRB 23(6):7-11.
68. Nelson, R. M. 2002. Appropriate risk exposure in environmental health research. the Kennedy-Krieger lead abatement study. Neurotoxicology and Teratolology 24(4): 445-9.
69. Norbert, P. W. and A. D. Roses. 2003. Pharmacogenetics and pharmacogenomics: Recent developments, their clinical relevance and some ethical, social, and legal implications. Journal of Molecular Medicine 81(3):135-40.
70. Olden, K. and S. Wilson. 2000. Environmental health and genomics: Visions and implications. Nature Reviews Genetics 1(2):149-53.
71. Omenn, G. S. 2000a. Genetics and public health: Historical perspectives and current challenges and opportunities. In Genetics and Public Health in the 21st Century. Using Genetic Information to Improve Health and Prevent Disease, edited by M. J. Khoury, W. Burke, and E. J. Thomson. New York: Oxford University Press.
72. Omenn, G. S. 2000b. Public health genetics: An emerging interdisciplinary field for the postgenomic era. Annual Review of Public Health 21:1-13.
73. Omenn, G. S. 2002. The crucial role of the public health sciences in the postgenomic era. Genetic Medicine 4(6 Suppl):21S-26S.
74. Pernick, M. S. 1997. Eugenics and public health in American history. American Journal of Public Health 87(11):1767-72.
75. Pesonen, L. M. 2002. Genetic screening: An employer's tool to differentiate or to discriminate? Journal of Contemporary Health Law & Policy 19(1):187-223.
76. Risch, N., E. Burchard, E. Ziv, and H. Tang. 2002. Categorization of humans in biomedical research: genes, race and disease. Genome Biology 3(7): comment 2007.
77. Roche, P. A. 2002. The genetic revolution at work: Legislative efforts to protect employees. American Journal of Law & Medicine 28(2-3):271-83.
78. Rothstein, M. A. 2002. Rethinking the meaning of public health. Journal of Law, Medicine & Ethics 30(2):144-9.
79. Rothstein, M. A. Ed. 2003. Pharmacogenomics: Social, ethical, and clinical dimensions. Hoboken, NJ: Wiley-Liss.
80. Rothstein, M. A. and P. G. Epps. 2001. Ethical and legal implications of pharmacogenomics. Nature Reviews Genetics 2(3):228-31.
81. Schulte, P. A. and G. Lomax. 2003. Assessment of the scientific basis for genetic testing of railroad workers with carpal tunnel syndrome. Journal of Occupational and Environmental Medicine 45(6):592-600.
82. Schulte, P. A., G. P. Lomax, E. M. Ward, and M. J. Colligan. 1999. Ethical issues in the use of genetic markers in occupational epidemiologic research. Journal of Occupational and Environmental Medicine 41(8):639-46.
83. Shamoo, A. E. 2002. Ethically questionable research with children: The Kennedy Krieger Lead Abatement study. Accountability in Research 9(3-4):167-75.
84. Sharp, R. R. 2001. The evolution of predictive genetic testing: Deciphering geneenvironment interactions. Jurimetrics 41(2):145-63.
85. Sharp, R. R. and J. C. Barrett. 1999. The Environmental Genome Project and bioethics. Kennedy Institute of Ethics Journal 9(2):175-88.
86. Sharp, R. R. and J. C. Barrett. 2000. The environmental genome project: Ethical, legal, and social implications. Environmental Health Perspectives 108(4):279-81.
87. Sheinfeld Gorin, S. and S. M. Albert. 2003. The meaning of risk to first degree relatives of women with breast cancer. Women & Health 37(3):97-117.
88. Shields, P. G. and C. C. Harris. 2000. Cancer risk and low-penetrance susceptibility genes in gene-environment interactions. Journal of Clinical Oncology 18(11): 2309-15.
89. Sotos, J. G. and H. Y. Rienhoff, Jr. 2000. Will genetics revolutionize medicine? New England Journal of Medicine 343(20):1496; discussion 1498.
90. Stephens, J. W. and S. E. Humphries. 2003. The molecular genetics of cardiovascular disease: clinical implications. Journal of Internal Medicine 253(2):120-7.
91. Sunde, R. A. 2001. Research needs for human nutrition in the post-genome-sequencing era. The Journal of Nutrition 131(12):3319-23.
92. Susser, E. and M. B. Terry. 2003. A conception-to-death cohort. Lancet 361(9360): 797-8.
93. Swallen, K. C. 2003. Race and genomics. New England Journal of Medicine 348(25): 2581-2.
94. Swan, G. E. 1999. Implications of genetic epidemiology for the prevention of tobacco use. Nicotine & Tobacco Research (1 Suppl 1):S49-56.
95. Swan, G. E., K. S. Hudmon, L. M. Jack, K. Hemberger, D. Carmelli, T. V. Khroyan, H. Z. Ring, H. Hops, J. A. Andrews, E. Tildesley, D. McBride, N. Benowitz, C. Webster, K. C. Wilhelmsen, H. S. Feiler, B. Koenig, L. Caron, J. Illes, and L. S. Cheng. 2003. Environmental and genetic determinants of tobacco use: Methodology for a multidisciplinary, longitudinal family-based investigation. Cancer Epidemiology, Biomarkers & Prevention 12(10):994-1005.
96. Taylor, A. L., S. Ziesche, C. Yancy, P. Carson, R. D'Agostino Jr, K. Ferdinand, M. Taylor, K. Adams, M. Sabalinski, M. Worcel, J. N. Cohn. 2004. Combination of isosorbide dinitrate hydralazine in blacks with heart failure. New England Journal of Medicine 351(20):2049-57.
97. Theodorou, I., C. Capoulade, C. Combadiere, and P. Debre. 2003. Genetic control of HIV disease. Trends in Microbiology 11(8):392-7.
98. Tiret, L. 2002. Gene-environment interaction: A central concept in multifactorial diseases. Proceedings of the Nutrition Society 61(4):457-63.
99. Ward, E. M., P. A. Schulte, S. Bayard, A. Blair, P. Brandt-Rauf, M. A. Butler, D. Dankovic, A. F. Hubbs, C. Jones, M. Karstadt, G. L. Kedderis, R. Melnick, C. A. Redlich, N. Rothman, R. E. Savage, M. Sprinker, M. Toraason, A. Weston, A. F. Olshan, P. Stewart, and S. H. Zahm. 2003. Priorities for development of research methods in occupational cancer. Environmental Health Perspectives 111(1):1-12.
100. Wicks, A. C., L. E. Sever, R. Harty, S. W. Gajewski, and M. Marcus-Smith. 1999. Screening workers for genetic hypersusceptibility: Potential ethical, legal, and social implications from the Human Genome Project. Journal of Health and Human Services Administration 22(1):116-32.
101. Wilcox, A. J., J. A. Taylor, R. R. Sharp, and S. J. London. 1999. Genetic determinism and the overprotection of human subjects. Nature Genetics 21(4):362.
102. Williams, S. M. and A. R. Templeton. 2003. Race and genomics. New England Journal of Medicine 348(25):2581-2.